Omada Health director receives 1,544-share RSU grant

Omada Health, Inc. director Jeryl L. Hilleman received an equity grant in the form of restricted stock units.

Rhea-AI Filing Summary

Omada Health, Inc. director Jeryl L. Hilleman received an equity grant in the form of restricted stock units. The filing reports an acquisition of 1,544 shares of Common Stock at a stated price of $0.00 per share, classified as a grant or award rather than a market purchase.

The RSUs were granted under the company’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU represents the right to receive one share of Common Stock upon settlement. After this award, Hilleman directly holds 14,338 shares of Omada Health common stock.

Insider Trade Summary

Grant/Award: 1,544 shares

Grant/Award 1 txn

Insider HILLEMAN JERYL L

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,544	$0.00	$0.00

Holdings After Transaction: Common Stock — 14,338 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

Key Figures

RSU grant size: 1,544 shares Grant price per share: $0.00 per share Shares owned after transaction: 14,338 shares +3 more

6 metrics

RSU grant size 1,544 shares Restricted stock units granted to director on April 5, 2026

Grant price per share $0.00 per share Stated transaction price for RSU award

Shares owned after transaction 14,338 shares Director’s total direct holdings after RSU grant

Buy transactions 0 Open-market purchase count in transaction summary

Sell transactions 0 Open-market sale count in transaction summary

Acquire transactions 1 Grant/award acquisition count in transaction summary

Key Terms

restricted stock units ("RSUs"), Non-Employee Director Compensation Program, retainer fees, settlement

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

Non-Employee Director Compensation Program financial

"were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees"

retainer fees financial

"granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees"

settlement financial

"Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected"

Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Omada Health (OMDA) disclose in this Form 4?

Omada Health disclosed that director Jeryl L. Hilleman received a grant of 1,544 restricted stock units of Common Stock. The award is classified as a grant or other acquisition, not an open-market purchase or sale, and relates to director compensation.

How many Omada Health (OMDA) shares does the director hold after this grant?

Following the RSU grant, director Jeryl L. Hilleman is reported to beneficially own 14,338 shares of Omada Health Common Stock directly. This total includes the 1,544-share award disclosed in the transaction and reflects her updated direct ownership position.

Was cash paid for the Omada Health (OMDA) RSU grant reported in this filing?

No cash was paid by the director for this award. The Form 4 lists 1,544 shares of Common Stock acquired at a $0.00 per share transaction price, indicating a compensation-related restricted stock unit grant rather than a cash purchase in the market.

What is the nature of the RSUs granted to the Omada Health (OMDA) director?

The reported restricted stock units (RSUs) were granted under Omada Health’s Non-Employee Director Compensation Program in lieu of cash retainer fees. Each RSU entitles the director to receive one share of Common Stock upon settlement, according to the program’s terms.

Does the Omada Health (OMDA) Form 4 indicate any insider share sales?

The Form 4 does not report any insider sales. It shows a single transaction coded as “A” for grant, award, or other acquisition of 1,544 RSUs, and the transaction_summary indicates zero sell transactions or dispositions in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/07/2026 - 04:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HILLEMAN JERYL L

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/05/2026		A		1,544(1)	A	$0	14,338	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") that were granted pursuant to the Issuer's Non-Employee Director Compensation Program (the "Program") in lieu of retainer fees. Each RSU represents the right to receive one (1) share of Common Stock, with settlement to take place either (i) on a date selected by the Reporting Person pursuant to the Program or (ii) as otherwise provided by the Program.

	/s/ Nathan Salha, as Attorney-in-Fact for Jeryl L. Hilleman	04/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)